Skip to content

Indirect Calorimetry-Guided Parenteral Nutrition Prescribing in Oncology Patients

Comparing Measured Resting Energy Expenditure to Weight-Based Equations for Parenteral Nutrition Prescribing in Oncology Patients: A Randomized Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07776704
Enrollment
50
Registered
2026-08-20
Start date
2025-08-21
Completion date
2029-01-01
Last updated
2026-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Malnutitrion

Keywords

Parenteral Nutrition, Indirect Calorimetry, Oncology, Resting Energy Expenditure, Quality of Life

Brief summary

This study compares two methods of prescribing parenteral nutrition (PN) in adults with cancer who are unable to meet nutritional needs by oral or enteral intake.

Detailed description

This is a single-center, randomized, open-label pilot study enrolling 50 adult oncology patients requiring PN (parenteral nutrition). Participants are randomized to weight-based dosing or indirect calorimetry-guided dosing. Outcomes include feasibility, acceptability, changes in PN prescription, adverse events, quality of life, and survival.

Interventions

DEVICEIndirect Calorimeter

Q-NRG + metabolic monitor

DIETARY_SUPPLEMENTWeight-Based Parenteral Nutrition Dosing

Parenteral nutrition dosed using standard weight-based equations.

Sponsors

Fox Chase Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged ≥18 years * Diagnosis of cancer * Requirement for PN ≥1 week * Ability to provide informed consent * English-speaking

Exclusion criteria

* Hospice enrollment * Mechanical ventilation * Chest tube or drain * Continuous renal replacement therapy * Supplemental oxygen

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants in the Indirect Calorimetry Arm Completing at Least 50% of Scheduled Indirect Calorimetry MeasurementsUp to 8 weeksFeasibility will be assessed as the proportion of participants randomized to the indirect calorimetry intervention arm who complete at least 50% of scheduled indirect calorimetry measurements during the 8-week intervention period. Scheduled measurements will occur weekly while inpatient and every 4 weeks while outpatient per protocol.
Participant Acceptability of Indirect Calorimetry Measured by a 5-Point Likert QuestionnaireBaseline, Week 4, and Week 8Acceptability will be assessed using a 7-item participant questionnaire developed for this study evaluating comfort, understanding, satisfaction, and willingness to undergo indirect calorimetry again. Five items are scored on a 5-point Likert scale ranging from 1 (Strongly disagree) to 5 (Strongly agree). Higher scores indicate greater acceptability of indirect calorimetry. Acceptability will be summarized using mean questionnaire scores and the percentage of participants reporting agreement or strong agreement with overall acceptability.

Secondary

MeasureTime frameDescription
Percentage Change in Prescribed Parenteral Nutrition Energy Dose Following Indirect Calorimetry MeasurementUp to 3 monthsThe outcome will assess the percentage change in prescribed parenteral nutrition caloric dose (kcal/day) after indirect calorimetry measurement compared with the initial weight-based prescription. Changes in PN dosing attributable to indirect calorimetry-guided resting energy expenditure measurements will be recorded at each reassessment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 21, 2026